Skip to content

Postpartum Ultrasound Evaluation to Assess Risk of Hemorrhage

Postpartum Ultrasound Evaluation to Assess Risk of Hemorrhage

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06898034
Enrollment
1725
Registered
2025-03-27
Start date
2025-03-10
Completion date
2027-03-31
Last updated
2025-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post Partum Hemorrhage, Pregnancy Related

Brief summary

Up to 5% of patients in the United States have a postpartum hemorrhage. Postpartum hemorrhage means excessive bleeding after delivery. The majority of these bleeds occur immediately with delivery. The current study focuses on hemorrhages that occur in the medium-term (1.5-24 hours after delivery). Investigators are examining whether ultrasound exams performed at the beginning of this period 1.5 to 2 hours after birth can identify markers that predict a medium-term bleed. Data collected for this study will include medical and obstetrical history, details about the course and outcomes of patients' labor and delivery, and particulars about postpartum bleeding. This information will be collected through the end of the patients' delivery admission and will allow correlation with the results of the ultrasound exam. If patients are re-admitted to the hospital after the delivery discharge, investigators may also collect relevant information about those admissions up to 6 weeks postpartum. All patients after term delivery (≥ 37 weeks' gestation) will be eligible to participate. Patients will be approached to provide consent for participation as early as feasible during a prenatal visit (≥ 36 weeks' gestation) or during the delivery admission. No subjects will be consented while in significant pain, \>6cm dilated without an epidural, or \>8cm dilatated with an epidural.

Interventions

OTHERUltrasound

Postpartum ultrasound exam

Sponsors

Endeavor Health
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
17 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Currently pregnant and planning to deliver at Endeavor Health \>37 weeks gestational age * English speaking * Labor \<6cm dilated at time of consent without epidural * Labor \<8cm dilated at time of consent with epidural

Exclusion criteria

* Preterm delivery * Non-English speaking * Any conditions that impairs potential participants decision making

Design outcomes

Primary

MeasureTime frameDescription
Ultrasound exam: uterine measurementsFrom enrollment to 1.5-2 hours post partum* Uterine length (cm) * Uterine width (cm) * Uterine height (cm) These will be correlated with subsequent clinical outcomes, including bleeding events.
Ultrasound exam: endometrial stripeFrom enrollment to 1.5-2 hours post partumWidth (cm) of the endometrial stripe (measuring displacement of the uterine walls by intrauterine contents (blood, clots, retained placental fragments or other) to include Doppler study) at 3 levels: * Fundal * Lower uterine segment * Cervix These will be correlated with subsequent clinical outcomes, including bleeding events.
Ultrasound exam:fibroidsFrom enrollment to 1.5-2 hours post partumPresence of uterine fibroids (number and size in cm of each) These will be correlated with subsequent clinical outcomes, including bleeding events.
Ultrasound exam: VaginaFrom enrollment to 1.5-2 hours post partumCaliber of the vagina (cm) (to assess distension by clot) These will be correlated with subsequent clinical outcomes, including bleeding events.
Ultrasound exam: BladderFrom enrollment to 1.5-2 hours post partum* Bladder length (cm) * Bladder height (cm) * Bladder width (cm) All other aspects of clinical management will be left to the discretion of the clinical team. These will be correlated with subsequent clinical outcomes, including bleeding events.

Secondary

MeasureTime frameDescription
Chart reviewFrom enrollment to 6 weeks post partumOutcome measures for this study will include details about the postpartum course up to 6 weeks postpartum. This will allow correlation with the results of the ultrasound exam. If patients are re-admitted to the hospital after the delivery discharge, investigators will also collect relevant information about those admissions.

Countries

United States

Contacts

Primary ContactKate Honeyfield
KHoneyfield@northshore.org847-570-2243

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026